Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 5.38 | 4.65 |
| PEG Ratio (TTM) | -1.38 | -5.74 |
| P/S Ratio (TTM) | 0.07 | 1.04 |
| P/B Ratio (TTM) | 0.09 | 1.42 |
| P/FCF Ratio (TTM) | -2.81 | 9.79 |
| Price to 5YR AVG Earnings Ratio | N/A | 21.91 |
| Price to 5YR AVG FCF Ratio | N/A | 4.23 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.45% | -1.07% |
| ROE (TTM) | 1.72% | 3.06% |
| Net Profit Margin (TTM) | 1.07% | -1.49% |
| ROIC 5YR AVG | N/A | 9.09% |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -7,157.06% | -1,036.95% | N/A |
| Revenue | -0.13% | 0.71% | N/A |
| Net Income | -1,185.91% | -1,046.38% | N/A |
| Cash Flow | -285.00% | 153.10% | N/A |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.60 | 1.29 |
| Quick Ratio (TTM) | 1.60 | 1.29 |
| D/E Ratio (TTM) | 1.82 | 1.04 |
| Interest Coverage (TTM) | 0.33 | 4.34 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 0.72 | 1.25 |
| LTL to 5YR AVG FCF | N/A | 7.75 |
| Shares Outstanding Growth 5YR AVG | N/A | 7.36% |